We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.18B
AUM Growth
-$419M
Cap. Flow
-$653M
Cap. Flow %
-12.61%
Top 10 Hldgs %
12.12%
Holding
1,157
New
156
Increased
241
Reduced
474
Closed
210

Sector Composition

Rank Sector Weight
1 Technology 18.78%
2 Financials 17.57%
3 Healthcare 14.1%
4 Industrials 10.7%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHMA
876
DELISTED
Chiasma, Inc. Common Stock
CHMA
$126K ﹤0.01%
+64,576
New +$147K
MRVC
877
DELISTED
MRV Communications Inc
MRVC
$126K ﹤0.01%
15,448
-6,890
-31% -$64.8K
RNWK
878
DELISTED
RealNetworks Inc
RNWK
$125K ﹤0.01%
25,803
-28,497
-52% -$134K
PRTS icon
879
CarParts.com
PRTS
$42.8M
$124K ﹤0.01%
3,520
-5,150
-59% -$159K
PCTI
880
DELISTED
PCTEL, Inc. Common Stock
PCTI
$121K ﹤0.01%
22,517
-17,900
-44% -$93.1K
ICAD
881
DELISTED
iCAD Inc
ICAD
$120K ﹤0.01%
37,197
-4,900
-12% -$18.6K
TZOO icon
882
Travelzoo
TZOO
$103M
$120K ﹤0.01%
+12,800
New +$142K
DRH icon
883
Diamondrock Hospitality Co
DRH
$2.63B
$118K ﹤0.01%
10,200
-5,450
-35% -$55.1K
PRCP
884
DELISTED
Perceptron Inc
PRCP
$118K ﹤0.01%
17,790
-20,210
-53% -$130K
HDNG
885
DELISTED
Hardinge Inc
HDNG
$118K ﹤0.01%
10,682
-22,633
-68% -$238K
CBIO
886
Crescent Biopharma
CBIO
$602M
$117K ﹤0.01%
192
-74
-28% -$46.2K
VVUS
887
DELISTED
Vivus Inc
VVUS
$115K ﹤0.01%
+9,990
New +$120K
ASYS icon
888
Amtech Systems
ASYS
$278M
$114K ﹤0.01%
26,734
-6,900
-21% -$31.3K
EVRI
889
DELISTED
Everi Holdings
EVRI
$114K ﹤0.01%
52,400
+25,200
+93% +$58.5K
PAR icon
890
PAR Technology
PAR
$637M
$113K ﹤0.01%
20,273
-16,619
-45% -$88K
MTEM
891
DELISTED
Molecular Templates, Inc.
MTEM
$113K ﹤0.01%
1,558
+288
+23% +$22K
NAVB
892
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$113K ﹤0.01%
+8,880
New +$141K
DHX icon
893
DHI Group
DHX
$166M
$112K ﹤0.01%
+17,906
New +$115K
PHLT
894
DELISTED
Performant Healthcare Inc
PHLT
$112K ﹤0.01%
47,702
-21,458
-31% -$68.9K
CDI
895
DELISTED
CDI Corp.
CDI
$112K ﹤0.01%
15,077
-43,426
-74% -$298K
HBP
896
DELISTED
Huttig Building Products, Inc.
HBP
$111K ﹤0.01%
16,753
PSTB
897
DELISTED
Park Sterling Corp.
PSTB
$111K ﹤0.01%
10,300
-800
-7% -$7.46K
VXRT
898
DELISTED
Vaxart
VXRT
$110K ﹤0.01%
8,127
COVS
899
DELISTED
Covisint Corporation
COVS
$110K ﹤0.01%
57,805
-47,241
-45% -$102K
DALN
900
DELISTED
DallasNews
DALN
$109K ﹤0.01%
4,293
-2,736
-39% -$71.2K

Similar funds

Jacobs Levy Equity Management's Q4 2016 Portfolio in Review

As of Q4 2016, Jacobs Levy Equity Management held 1,157 positions worth $5.18B, down 7.5% from $5.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $653M in Q4 2016, closing 210 positions and reducing 474 holdings. Its most notable exit was Nike, an estimated $39.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Express Scripts Holding Company worth $34.6M.

  • Jacobs Levy Equity Management's largest Q4 2016 buy was Express Scripts Holding Company: 502,999 shares worth $34.6M.
  • Jacobs Levy Equity Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2016, an estimated $34.6M increase.
  • Jacobs Levy Equity Management's biggest Q4 2016 reduction was Alphabet (Google) Class C, cutting an estimated $34.2M.
  • Jacobs Levy Equity Management fully exited Nike in Q4 2016, selling an estimated $39.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.18B portfolio in Q4 2016.
  • Jacobs Levy Equity Management opened 156 new positions and closed 210 in Q4 2016.
  • Jacobs Levy Equity Management's portfolio value fell 7.5% quarter-over-quarter to $5.18B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2016, filed 14 Feb 2017.